Skip to main navigation Skip to search Skip to main content

Novel electrosprayed core-shell polyethyleneimine and phospholipid coated MSNs for Co-delivery of KAZ3 and MDR-1 siRNA for efficient chemotherapy in multidrug-resistant colon cancer

  • Elshaimaa Sayed
  • , Ketan Ruparelia
  • , Saman Zafar
  • , Ahmed Faheem
  • , Dimitris Fatouros
  • , Muhammad Sohail Arshad
  • , Neenu Singh
  • , Zeeshan Ahmad
  • Minia University
  • De Montfort University
  • Bahauddin Zakariya University
  • Tanta University
  • Aristotle University of Thessaloniki

Research output: Contribution to journal › Article › peer-review

Abstract

Different strategies and multifunctional nano-carriers have been employed to enhance chemotherapeutic drugs bioavailability and tackle acquired multi-drug resistance (MDR) thus ensuring efficient chemotherapy with fewer adverse effects. Among these, mesoporous Silica Nanoparticles (MSNs) are exciting matrices for improving cytotoxic drugs bioavailability and circumventing MDR through its potential of co-delivery of anticancer agents and short interfering RNA (siRNA). In this study, MSNs were coated with (1:1) Polyethyleneimine (PEI) and phospholipids (PL) composite and were loaded with KAZ3 (Anticancer chalcone) using coaxial electrospraying in a one step process. The novel delivery system was used to co-deliver both MDR-1 siRNA and KAZ3 to colon cancer cell lines in order to knockdown the MDR-1 gene and thus to improve KAZ3 cytotoxicity. The prepared drug/siRNA delivery system was characterized using SEM, fluorescence microscopy, TGA, zeta sizer, actives (KAZ3 and siRNA) loading efficiency, actives release studies, siRNA gel retardation and actives cellular uptake. The cytotoxicity of formulations against cancer cell lines (HCT 116) was also assessed using MTT assay and MDR-1 gene silencing efficiency using western blotting. Results showed that coaxial electrospraying was efficient in preparing core-shell coated MSNs that were able to co-deliver both MDR-1 siRNA and KAZ3 to colon cancer lines. The MSNs coated with PL and 2.5 KDa PEI were found to be more compatible with human cells than to 25KDa PEI coated MSNs. KAZ3/siRNA loaded PEI-PL coated MSNs were successful in decreasing multidrug resistance gene expression to 40 % and causing up to 92 % colon cancer cell death. The findings of the present study show the immense potential of electro-hydrodynamic atomization (EHDA) as a technique for producing drug loaded MSNs based core-shell particles.

Original languageEnglish
Pages (from-to)114838
JournalEuropean Journal of Pharmaceutics and Biopharmaceutics
Volume215
DOIs
Publication statusPublished - Oct 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Humans
  • RNA, Small Interfering/administration & dosage
  • Polyethyleneimine/chemistry
  • Colonic Neoplasms/drug therapy
  • Drug Resistance, Neoplasm/drug effects
  • Phospholipids/chemistry
  • Drug Resistance, Multiple/drug effects
  • Nanoparticles/chemistry
  • ATP Binding Cassette Transporter, Subfamily B/genetics
  • Silicon Dioxide/chemistry
  • Cell Line, Tumor
  • Antineoplastic Agents/administration & dosage
  • Drug Delivery Systems/methods
  • Drug Carriers/chemistry

Fingerprint

Dive into the research topics of 'Novel electrosprayed core-shell polyethyleneimine and phospholipid coated MSNs for Co-delivery of KAZ3 and MDR-1 siRNA for efficient chemotherapy in multidrug-resistant colon cancer'. Together they form a unique fingerprint.

Cite this